Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19
Renuka Bankar,
Kruthi Suvarna,
Saicharan Ghantasala,
Arghya Banerjee,
Deeptarup Biswas,
Manisha Choudhury,
Viswanthram Palanivel,
Akanksha Salkar,
Ayushi Verma,
Avinash Singh,
Amrita Mukherjee,
Medha Gayathri J. Pai,
Jyotirmoy Roy,
Alisha Srivastava,
Apoorva Badaya,
Sachee Agrawal,
Om Shrivastav,
Jayanthi Shastri,
Sanjeeva Srivastava
Affiliations
Renuka Bankar
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Kruthi Suvarna
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Saicharan Ghantasala
Centre for Research in Nanotechnology and Sciences, Indian Institute of Technology Bombay, India
Arghya Banerjee
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Deeptarup Biswas
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Manisha Choudhury
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Viswanthram Palanivel
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Akanksha Salkar
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Ayushi Verma
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Avinash Singh
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Amrita Mukherjee
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Medha Gayathri J. Pai
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Jyotirmoy Roy
Department of Chemical Engineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Alisha Srivastava
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India; University of Delhi, New Delhi, Delhi 110021, India
Apoorva Badaya
Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India
Sachee Agrawal
Kasturba Hospital for Infectious Diseases, Chinchpokli, Mumbai, Maharashtra 400034, India
Om Shrivastav
Kasturba Hospital for Infectious Diseases, Chinchpokli, Mumbai, Maharashtra 400034, India
Jayanthi Shastri
Kasturba Hospital for Infectious Diseases, Chinchpokli, Mumbai, Maharashtra 400034, India
Sanjeeva Srivastava
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India; Corresponding author
Summary: The altered molecular proteins and pathways in response to COVID-19 infection are still unclear. Here, we performed a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19 to study the host response by employing simple extraction strategies. Few of the host proteins such as interleukin-6, L-lactate dehydrogenase, C-reactive protein, Ferritin, and aspartate aminotransferase were found to be upregulated only in COVID-19-positive patients using targeted multiple reaction monitoring studies. The most important pathways identified by enrichment analysis were neutrophil degranulation, interleukin-12 signaling pathways, and mRNA translation of proteins thus providing the detailed investigation of host response in COVID-19 infection. Thus, we conclude that mass spectrometry-detected host proteins have a potential for disease severity progression; however, suitable validation strategies should be deployed for the clinical translation. Furthermore, the in silico docking of potential drugs with host proteins involved in the interleukin-12 signaling pathway might aid in COVID-19 therapeutic interventions.